Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | GBA1 | P04062 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | APAF1 | O14727 | 1/20 | 0.34 |
| ▸ | NSD2 | O96028 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9961617 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL17773082 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL14555970 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL19807973 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL23541364 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL11962132 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL24862325 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL15746583 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL22923476 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 | |
| SCHEMBL14684293 | 1.00 | FUCA1 (0.48) | FUCA1CA2CA9CA12GBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023066885-A1 | SAPONIN PRODUCTION | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-04-27 | — | — | WO | disclosed |
| US-20180020708-A1 | GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS | PEPSICO, INC. | 2018-01-25 | — | — | US | disclosed |
| US-9670247-B2 | Contraceptive agents | THE UNIVERSITY OF KANSAS (US) | 2017-06-06 | — | — | US | disclosed |
| US-9670247-B2 | Contraceptive agents | THE UNIVERSITY OF KANSAS (US) | 2017-06-06 | — | — | US | disclosed |
| EP-1370566-B1 | SYNTHETIC DERIVATIVES OF 21-BUTENYL AND RELATED SPINOSYNS | DOW AGROSCIENCES LLC (US) | 2017-04-19 | — | — | EP | disclosed |
| US-20130035321-A1 | COMPOUNDS FOR THE TREATMENT OF OCULAR CANCER | ANALYTICON DISCOVERY GMBH (DE) | 2013-02-07 | — | — | US | disclosed |
| WO-2011068876-A1 | COMPOUNDS FOR THE TREATMENT OF OCULAR CANCER | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2011-06-09 | — | — | WO | disclosed |
| US-7605241-B2 | Synthesis of inhibitors of p90Rsk | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2009-10-20 | — | — | US | disclosed |
| US-20080269144-A1 | Synthesis of Inhibitors of P90Rsk | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269144-A1 | Synthesis of Inhibitors of P90Rsk | RAF1, KSR1, STK10 | FUCA1 1808/4885CA2 4753/4885CA9 4843/4885 |
| US-20130035321-A1 | COMPOUNDS FOR THE TREATMENT OF OCULAR CANCER | RB1, MKI67, ING2 | FUCA1 1331/4885CA2 772/4885CA9 252/4885 |
| US-20180020708-A1 | GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS | GPR119, TAS2R42, TAS2R31 | FUCA1 562/4885CA2 1101/4885CA9 940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.